Definium Therapeutics (DFTX) Other Working Capital Changes (2019 - 2026)
Definium Therapeutics (DFTX) reported Other Working Capital Changes of -$585000.0 for Q1 2026, down 142.39% year-over-year from $1.4 million in Q1 2025, and down 124.0% on a QoQ basis from $2.4 million in Q4 2025.
Definium Therapeutics (DFTX) has 7 years of Other Working Capital Changes data on file, last reported at -$585000.0 in Q1 2026.
- Quarterly Other Working Capital Changes fell 142.39% year-over-year to -$585000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.1 million (down 134.23% YoY) and the FY2025 annual result came in at -$152000.0, down 103.5% from the prior year.
- Other Working Capital Changes declined to -$585000.0 in Q1 2026 per DFTX's latest filing, from $2.4 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $3.8 million in Q4 2024 and bottomed at -$3.1 million in Q2 2025.
- The 5-year median for Other Working Capital Changes is -$468000.0 (2024), against an average of $224764.7.
- The widest annual swing landed in 2024, when Other Working Capital Changes surged 1476.85%; it then plunged 309.55% in 2025.
- Tracing DFTX's Other Working Capital Changes over 5 years: stood at $2.1 million in 2022, then decreased by 26.75% to $1.5 million in 2023, then soared by 147.72% to $3.8 million in 2024, then tumbled by 35.93% to $2.4 million in 2025, then slumped by 124.0% to -$585000.0 in 2026.
- Per Business Quant, the three latest DFTX Other Working Capital Changes figures stand at -$585000.0 (Q1 2026), $2.4 million (Q4 2025), and -$854000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Definium Therapeutics | 2.42 Bn | 2.06 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -585,000.00 |
| Mar 31, 2026 | -585,000.00 |
| Dec 31, 2025 | 2.44 Mn |
| Dec 31, 2025 | 2.44 Mn |
| Sep 30, 2025 | -854,000.00 |
| Sep 30, 2025 | -854,000.00 |
| Jun 30, 2025 | -3.12 Mn |
| Jun 30, 2025 | -3.12 Mn |
| Mar 31, 2025 | 1.38 Mn |
| Mar 31, 2025 | 1.38 Mn |
| Dec 31, 2024 | 3.81 Mn |
| Dec 31, 2024 | 3.81 Mn |
| Sep 30, 2024 | -487,000.00 |
| Sep 30, 2024 | -487,000.00 |
| Jun 30, 2024 | 1.49 Mn |
| Jun 30, 2024 | 1.49 Mn |
| Mar 31, 2024 | -468,000.00 |
| Mar 31, 2024 | -468,000.00 |
| Dec 31, 2023 | 1.54 Mn |
| Dec 31, 2023 | 1.54 Mn |
| Sep 30, 2023 | -558,000.00 |
| Sep 30, 2023 | -558,000.00 |
| Jun 30, 2023 | -108,000.00 |
| Jun 30, 2023 | -108,000.00 |
| Mar 31, 2023 | -909,000.00 |
| Mar 31, 2023 | -909,000.00 |
| Dec 31, 2022 | 2.10 Mn |
| Dec 31, 2022 | 2.10 Mn |
| Sep 30, 2022 | -1.30 Mn |
| Sep 30, 2022 | -1.30 Mn |
| Jun 30, 2022 | 381,000.00 |
| Jun 30, 2022 | 381,000.00 |
| Mar 31, 2022 | -922,000.00 |
| Mar 31, 2022 | -922,000.00 |
| Dec 31, 2021 | 3.09 Mn |
| Dec 31, 2021 | 3.09 Mn |
| Sep 30, 2021 | -871,000.00 |
| Sep 30, 2021 | -871,000.00 |
| Jun 30, 2021 | -788,000.00 |
| Jun 30, 2021 | -788,000.00 |
| Mar 31, 2021 | 732,000.00 |
| Mar 31, 2021 | 732,000.00 |
| Dec 31, 2019 | 34,000.00 |
| Dec 31, 2019 | 34,000.00 |